Drug-Resistant Early-Onset Progressive Myoclonic Epilepsy Revealing Lafora Disease: A Case Report. [PDF]
Pejanovic-Skobic N +5 more
europepmc +1 more source
Exploring the role of apolipoprotein ε4 in progressive myoclonic epilepsy type 1. [PDF]
Gunnar J +10 more
europepmc +1 more source
Lafora body disease: a case of progressive myoclonic epilepsy. [PDF]
Kaur R, Balaini N, Sharma S, Sharma SK.
europepmc +1 more source
Progressive Myoclonic Epilepsy'-like presentation of Cerebrotendinous Xanthomatosis in an Indian Family with A Novel C.646+1G>A Splice Site Mutation. [PDF]
Desai KM +6 more
europepmc +1 more source
PhDAims: The aim of this thesis was firstly, to prospectively examine cognitive function in relation to epilepsy, with event-related potential (ERP) and neuropsychological assessments, over a one year period.
Sharma, Simeran
core
Expanding the spectrum of <i>NUS1</i>-related progressive myoclonic epilepsy: a novel variant and exploratory use of metformin. [PDF]
Sau C +9 more
europepmc +1 more source
Myoclonic status in non-progressive encephalopaties (MSNPE)
The Authors review the electroclinical pictures of a large population of 37 females and 21 males outlining the existance of an epileptic syndrome characterized by the recurrence of long-lasting myoclonic status in children with a non progressive ...
DALLA BERNARDINA, Bernardo +2 more
core
A CGG Repeat Expansion in CSNK1E Associated with Progressive Myoclonic Epilepsy with Incomplete Penetrance. [PDF]
Akçimen F +13 more
europepmc +1 more source
[Efficacy of zonisamide in Lafora's disease case and brief review of its use in progressive myoclonic epilepsy]. [PDF]
Rubio-Nazábal E +3 more
europepmc +1 more source
Lafora disease presented with juvenile myoclonic epilepsy clinical features
Lafora Hastalığı Progressif Myoklonik Epilepsi olgularının %10 kadarını oluşturmaktadır. Sıklıkla 10-18 yaş arası ortaya çıkan ve otozomal resessif olarak kalıtılan bu hastalık, her iki cinside eşit olarak etkilemektedir.
G. Kandiloğlu +4 more
core

